Skip to main content
Home

Main navigation

  • Home
  • About
  • Team
  • Investments
  • News
  • Contact
Paratek
September 21, 2023
Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.

Read

Radius Health
September 20, 2023
Radius Health Announces Expansion of its Bone Health Business Through the Exclusive Licensing of U.S. Rights to BINOSTO® for Osteoporosis

Read

Radius Health
August 14, 2023
Radius Announces Royalty Purchase Agreement With DRI Healthcare to Sell a Portion of Its Royalty and Commercial Milestone Interest in elacestrant for up to $140 Million

Read

Corium International logo
August 10, 2023
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia

Read

Alladapt Immunotherapeutics logo
June 13, 2023
Alladapt Immunotherapeutics Announces Topline Pediatric Data from Phase 1/2 Harmony Study Evaluating ADP101

Read

Paratek
June 6, 2023
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings

Read

Corium Innovations Logo
June 6, 2023
Corium Pharma Solutions, Inc. is Now Corium Innovations, Inc.

Read

Naveris logo
April 12, 2023
Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer

Read

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Gurnet Point Capital
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Contact Us

Gurnet Point Capital © 2023. Please take a moment to read the Legal Notice / Privacy Statement.